Publication
Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes
Marja-Riitta Taskinen, Elias Björnson, Juhani Kahri, Sanni Söderlund, Niina Matikainen, Kimmo Porthan, Mari Ainola, Antti Hakkarainen, Nina Lundbom, Valentina Fermanelli, Johannes Fuchs, Annika Thorsell, Florian Kronenberg, Linda Andersson, Martin Adiels, Chris J. Packard, Jan Borén
Arteriosclerosis Thrombosis and Vascular Biology, February 2021, Wolters Kluwer Health
DOI: 10.1161/atvbaha.120.315446